Skip to main content Accessibility help

B-vitamins and bone in health and disease: the current evidence

  • M. Clarke (a1), M. Ward (a1), J. J. Strain (a1), L. Hoey (a1), W. Dickey (a2) and H. McNulty (a1)...


Osteoporosis, a metabolic skeletal disease characterised by decreased bone mass and increased fracture risk, is a growing public health problem. Among the various risk factors for osteoporosis, calcium and vitamin D have well-established protective roles, but it is likely that other nutritional factors are also implicated. This review will explore the emerging evidence supporting a role for certain B-vitamins, homocysteine and the 677C→T polymorphism in the gene encoding the folate-metabolising enzyme methylenetetrahydrofolate reductase, in bone health and disease. The evidence, however, is not entirely consistent and as yet no clear mechanism has been defined to explain the potential link between B-vitamins and bone health. Coeliac disease, a common condition of malabsorption, induced by gluten ingestion in genetically susceptible individuals, is associated with an increased risk both of osteoporosis and inadequate B-vitamin status. Given the growing body of evidence linking low bone mineral density and/or increased fracture risk with low B-vitamin status and elevated homocysteine, optimal B-vitamin status may play an important protective role against osteoporosis in coeliac disease; to date, no trial has addressed this possible link.


Corresponding author

* Corresponding author: Professor H. McNulty, fax +44 28 70124965, email


Hide All
1. Peck, WA, Burckhardt, P, Christiansen, C et al. (1993) Consensus development conference – diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94, 646650.
2. Strom, O, Borgstrom, F, Kanis, JA et al. (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6, 59155.
3. Van Staa, TP, Dennison, EM, Leufkens, HGM et al. (2001) Epidemiology of fractures in England and Wales. Bone 29, 517522.
4. Prentice, A. (2001) The relative contribution of diet and genotype to bone development. Proc Nutr Soc 60, 4552.
5. Kanis, JA, McCloskey, EV, Johansson, H et al. (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24, 2357.
6. Kanis, JA, Alexeeva, L, Bonjour, JP et al. (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis – synopsis of a who report. Osteoporos Int 4, 368381.
7. Cummings, SR, Browner, W, Cummings, SR et al. (1993) Bone density at various sites for prediction of hip fractures. Lancet 341, 7275.
8. Marshall, D, Johnell, O & Wedel, H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312, 12541259.
9. Kanis, JA, McCloskey, EV, Johansson, H et al. (2010) Development and use of FRAXA (R) in osteoporosis. Osteoporos Int 21, 407413.
10. Michaelsson, K, Melhus, H, Ferm, H et al. (2005) Genetic liability to fractures in the elderly. Arch Intern Med 165, 18251830.
11. Tang, BMP, Eslick, GD, Nowson, C et al. (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370, 657666.
12. van Wijngaarden, JP, Doets, EL, Szczecinska, A et al. (2013) Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: a systematic review with meta-analyses. J Nutr Metab 2013, 486186.
13. Wang, H & Liu, C (2012) Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporos Int 23, 26252634.
14. McKinley, MC, McNulty, H, McPartlin, J et al. (2001) Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73, 759764.
15. Homocysteine Lowering Trialists’ Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316, 894898.
16. Schwahn, B & Rozen, R (2001) Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenomics 1, 189201.
17. Yamada, K, Chen, Z, Rozen, R et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98, 1485314858.
18. Malinow, M, Bostom, A & Krauss, R (1999) Homocyst(e)ine, diet, and cardiovascular diseases – a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99, 178182.
19. Frosst, P, Blom, HJ, Milos, R et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111113.
20. Molloy, A, Daly, S, Mills, J et al. (1997) Thermolabile variant of 5, 10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349, 15911593.
21. McNulty, H, Dowey le, RC, Strain, JJ et al. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation 113, 7480.
22. Botto, LD & Yang, Q (2000) 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151, 862877.
23. Wilcken, B, Bamforth, F, Li, Z et al. (2003) Geographical and ethnic variation of the 677C>T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet 40, 619625.
24. Refsum, H, Smith, A, Ueland, P et al. (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50, 332.
25. Mudd, S, Skovby, F, Levy, H et al. (1985) The natural-history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37, 131.
26. Maron, BA & Loscalzo, J (2009) The treatment of hyperhomocysteinemia. Annu Rev Med 60, 3954.
27. Eastell, R, Vieira, N, Yergey, A et al. (1992) Pernicious-anemia as a risk factor for osteoporosis. Clin Sci 82, 681685.
28. Goerss, J, Kim, C, Atkinson, E et al. (1992) Risk of fractures in patients with pernicious-anemia. J Bone Miner Res 7, 573579.
29. Dai, Z, Wang, R, Ang, LW et al. (2013) Dietary B vitamin intake and risk of hip fracture: the Singapore Chinese Health Study. Osteoporos Int 24, 20492059.
30. Yang, J, Hu, X, Zhang, Q et al. (2012) Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone 51, 376382.
31. Enneman, AW, Swart, KM, van Wijngaarden, JP et al. (2012) Association between plasma homocysteine and bone density and quality parameters in the elderly. Bone 50, S134S134.
32. LeBoff, MS (2009) Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 94, 12071213.
33. Gjesdal, C, Voliset, S, Ueland, P et al. (2007) Plasma homocysteine, folate, and vitamin B sub(12) and the risk of hip fracture: the Hordaland Homocysteine study. J Bone Miner Res 22, 747756.
34. Yazdanpanah, N, Zillikens, MC, Rivadeneira, F et al. (2007) Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: the Rotterdam study. Bone 41, 987994.
35. Dhonukshe-Rutten, R, Pluijm, S, de Groot, L et al. (2005) Homocysteine and vitamin B-12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20, 921929.
36. van Meurs, JBJ, Dhonukshe-Rutten, RAM, Pluijm, SMF et al. (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350, 20332041.
37. McLean, RR, Jacques, PF, Selhub, J et al. (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350, 20422049.
38. Kim, B, Koh, J, Ahn, SH et al. (2013) High serum total homocysteine levels accelerate hip bone loss in healthy premenopausal women and men. Bone 52, 5662.
39. Zhu, K, Beilby, J, Dick, IM et al. (2009) The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int 20, 11831191.
40. Gjesdal, CG, Vollset, SE, Ueland, PM et al. (2006) Plasma total homocysteine level and bone mineral density – the Hordaland homocysteine study. Arch Intern Med 166, 8894.
41. McLean, RR, Jacques, PF, Selhub, J et al. (2008) Plasma B Vitamins, Homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 93, 22062212.
42. Morris, M, Jacques, P & Selhub, J (2005) Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37, 234242.
43. Tucker, KL, Hannan, MT, Qiao, N et al. (2005) Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis study. J Bone Miner Res 20, 152158.
44. Cagnacci, A, Baldassari, F, Rivolta, G et al. (2003) Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 33, 956959.
45. Rumbak, I, Zizic, V, Sokolic, L et al. (2012) Bone mineral density is not associated with homocysteine level, folate and vitamin B-12 status. Arch Gynecol Obstet 285, 9911000.
46. Herrmann, M, Peter Schmidt, J, Umanskaya, N et al. (2007) The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med : CCLM/FESCC 45, 16211632.
47. Yazdanpanah, N, Uitterlinden, AG, Zillikens, MC et al. (2008) Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J Bone Miner Res 23, 8694.
48. Hong, X, Hsu, Y, Terwedow, H et al. (2007) Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone 40, 737742.
49. Abrahamsen, B, Madsen, JS, Tofteng, CL et al. (2005) Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 36, 577583.
50. Macdonald, HM, McGuigan, FE, Fraser, WD et al. (2004) Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 35, 957964.
51. McLean, RR, Karasik, D, Selhub, J et al. (2004) Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res 19, 410418.
52. Abrahamsen, B, Madsen, JS, Tofteng, CL et al. (2003) A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 18, 723729.
53. Miyao, M, Morita, H, Hosoi, T et al. (2000) Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 66, 190194.
54. Sato, Y, Honda, Y, Iwamoto, J et al. (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293, 10821088.
55. Gommans, J, Yi, Q, Eikelboom, JW et al. (2013) The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. BMC Geriatr 13, 88.
56. Sawka, AM, Ray, JG, Yi, Q et al. (2007) Randomized clinical trial of homocysteine level lowering therapy and fractures. Arch Int Med 167, 21362139.
57. Herrmann, M, Tami, A, Wildemann, B et al. (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44, 467475.
58. Lubec, B, Fang-Kircher, S, Lubec, T et al. (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315, 159162.
59. Kang, A & Trelstad, R (1973) Collagen defect in Homocystinuria. J Clin Invest 52, 25712578.
60. Thaler, R, Agsten, M, Spitzer, S et al. (2011) Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J Biol Chem 286, 55785588.
61. Saito, M, Fujii, K & Marumo, K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79, 160168.
62. Herrmann, M, Widmann, T, Colaianni, G et al. (2005) Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 51, 23482353.
63. Koh, J, Lee, Y, Kim, Y et al. (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21, 10031011.
64. Kim, DJ, Koh, J, Lee, O et al. (2007) Homocysteine enhances apoptosis in human bone marrow stromal cells (vol 39, pg 582, 2006). Bone 40, 554555.
65. Herrmann, M, Kranzlin, M, Pape, G et al. (2005) Relation of homocysteine, biochemical bone markers, and bone mineral density in peri- and postmenopausal women. Bone 36, S338S338.
66. McLean, RR & Hannan, MT (2007) B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology. Curr Osteoporos Rep 5, 112119.
67. Tyagi, N, Kandel, M, Munjal, C et al. (2011) Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J Orthopaed Res 29, 15111516.
68. van Schoor, NM, Swart, KMA, Pluijm, SMF et al. (2012) Cross-sectional and longitudinal association between homocysteine, vitamin B12 and physical performance in older persons. Eur J Clin Nutr 66, 174181.
69. Swart, KMA, Enneman, AW, van Wijngaarden, JP et al. (2013) Homocysteine and the methylenetetrahydrofolate reductase 677C ->T polymorphism in relation to muscle mass and strength, physical performance and postural sway. Eur J Clin Nutr 67, 743748.
70. Cagnacci, A, Bagni, B, Zini, A et al. (2008) Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42, 314320.
71. Holstein, JH, Herrmann, M, Splett, C et al. (2009) Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. Am J Clin Nutr 90, 14401445.
72. Enneman, AW, van der Velde, N, de Jonge, R et al. The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures. Bone 50, 14011405.
73. Vaes, BLT, Lute, C, van der Woning, SP et al. (2010) Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. Bone 46, 514523.
74. Holstein, JH, Herrmann, M, Splett, C et al. (2011) High bone concentrations of homocysteine are associated with altered bone morphology in humans. Br J Nutr 106, 378382.
75. Carmel, R, Lau, K, Baylink, D et al. (1988) Cobalamin and osteoblast-specific proteins. N Engl J Med 319, 7075.
76. Kim, G, Kim, C, Park, J et al. (1996) Effects of vitamin B-12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metab-Clin Exp 45, 14431446.
77. Merriman, NA, Putt, ME, Metz, DC et al. (2010) Hip fracture risk in patients with a diagnosis of Pernicious anemia. Gastroenterology 138, 13301337.
78. Masse, P, Delvin, E, Hauschka, P et al. (2000) Perturbations in factors that modulate osteoblast functions in vitamin B6 deficiency. Can J Physiol Pharmacol 78, 904911.
79. Green, T, McMahon, J, Skeaff, C et al. (2007) Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr 85, 460464.
80. Herrmann, M, Umanskaya, N, Traber, L et al. (2007) The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med 45, 17851792.
81. Bird, T & Levene, C (1982) Lysyl oxidase – evidence that pyridoxal-phosphate is a cofactor. Biochem Biophys Res Commun 108, 11721180.
82. Masse, P, Rimnac, C, Yamauchi, M et al. (1996) Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 18, 567574.
83. Green, PH & Jabri, B (2003) Coeliac disease. Lancet 362, 383391.
84. Larussa, T, Suraci, E, Nazionale, I et al. (2012) Bone mineralization in celiac disease. Gastroenterol Res Pract. vol. 2012, Article ID 198025. doi:10.1155/2012/198025.
85. Pazianas, M, Butcher, G, Subhani, J et al. (2005) Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake. Osteoporos Int 16, 5663.
86. Corazza, G, Disario, A, Cecchetti, L et al. (1995) Bone mass and metabolism in patients with celiac-disease. Gastroenterology 109, 122128.
87. Olmos, M, Antelo, M, Vazquez, H et al. (2008) Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 40, 4653.
88. Tilg, H, Moschen, AR, Kaser, A et al. (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57, 684694.
89. Fiore, CE, Pennisi, P, Ferro, G et al. (2006) Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Hormone Metab Res 38, 417422.
90. Dickey, W, Ward, M, Whittle, CR et al. (2008) Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery. Scand J Gastroenterol 43, 682688.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed